"The largest relative detractors in the quarter were ICON Public Limited Company (NASDAQ:ICLR), Novo Nordisk, and Adobe. The largest absolute detractors were ICON pic, Novo Nordisk, and L'Oreal. ICON ...
Novo Nordisk's head of commercial strategy and corporate affairs, Camilla Sylvest, has decided to leave the company, the ...
TUESDAY, March 25, 2025 (HealthDay News) -- Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up ...
Novo Nordisk’s (NVO) stock has dropped by 25% in March (on the Copenhagen exchange) to put it on track for its biggest ...
The largest absolute detractors were ICON plc, Novo Nordisk, and L'Oreal. Recent trial results for Novo Nordisk's next gen GLP-1, Cagrisema, came in below market expectations, sending the stock ...
Goldman Sachs analyst James Quigley maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of DKK822.00.
The business-software group claimed the top spot as Europe’s largest company by market value, dethroning Wegovy maker Novo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results